Screening and Case Finding About 2 to 7% of women over age 40 years may have slightly elevated serum TSH concentrations. The case for routine assessment of thyroid status is strongest in elderly

 


¾ Recent dose adjustment (TSH high, free T4 normal)

¾ Patient taking T3 (TSH low, free T4 normal)

¾ Patient noncompliant with hormone replacement

(TSH high, free T4 normal)

¾ Nonthyroidal illness

¾ Drugs affecting thyroid hormones: Glucocorticoids,

dopamine

¾ Thyroid hormone resistance (TSH high, free T4 high,

patient euthyroid)

¾ TSH-secreting tumor (TSH high, free T4 high, patient

hyperthyroid)

¾ During antithyroid drug therapy, there can be patients

who have persistent serum T3 excess, despite normal

or low serum T4 values.

Effects of Drugs on Thyroid Function

¾ Altered hypothalamic or pituitary function

¾ Altered biosynthesis or release of thyroid hormones

¾ Displacement of T4 and T3 from binding proteins

¾ Reduced peripheral conversions of T4 to T3

¾ Inhibition of peripheral hormone activity.

Drugs that Affect Results of Thyroid Function Tests

Drugs Effect Cause

Salicylates,

Phenylbutazone,

Diphenylhydantoin

Total T4 and T3

reduced, Free T4

normal

Inhibition of serum

protein binding

Propylthiouracil,

Methimazole,

Lithium, Iodides

Total T4 and T3

reduced

Inhibition of TSH

production or release

Propylthiouracil Total T3 reduced both

T4 and TSH high

Inhibition of

conversion of T4 to T3

Propranolol Total T3 reduced, T4

normal, TSH normal

Inhibition of

conversion of T4 to T3

Glucocorticoids Total T3 reduced, T4

and TSH low or normal

Inhibition of

conversion of T4 to T3

Oral radiographic

dyes

Total T3 reduced, both

T4 and TSH high

Inhibition of

conversion of T4 to T3

Dopamine,

L-dopa,

Glucocorticoids

Basal TSH and

response to TRH

reduced

Direct effect to inhibit

TSH production in

pituitary gland

Amiodarone,

Bensamide

(transient),

Metopramide,

Sulpiride

Basal TSH increased

TRH

Increased TSH

production

Relationship Between Serum Total T4 and Total T3

Concentrations in Various Disorders Serum T3 Concentration

Serum T4 Concentration

High Low Normal High

Iodide

deficiency,

T3

treatment,

Antithyroid

drug therapy

T3 –

thyrotoxicosis,

T3 –

binding autoantibodies,

Thyrotoxicosis

of any cause,

Excess T4

ingestion

Thyroid hormone

resistance,

TBG excess,

Normal Iodine

deficiency,

T3

treatment,

Hypothyroidism

T4 treatment,

Euthyroid hyperthyroxinemia,

Thyrotoxicosis

with acute or

moderate

nonthyroidal

illness, T4 binding

autoantibodies

Low Severe

hypothyroidism, TBG

deficiency,

Drugs,

Severe

nonthyroidal

illness,

Acute and

chronic

non-thyroidal

illness,

Drugs,

Fetal life,

Restricted

nutrition

Thyrotoxicosis

with severe

nonthyroidal

illness,

750 Concise Book of Medical Laboratory Technology: Methods and Interpretations Relationship Between Serum FT4,

FT3 and TSH Concentrations in Various Disorders Serum TSH Concentration

Serum T4 Concentration

High High Normal Low

TSH-secreting

tumor (rare)

(FT3 = ↑)

Borderline/

compensated

hypothyroidism,

Hypothyroid

(primary),

Recovery from

sick euthyroid

state,

Normal Euthyroid

with T4

autoantibodies

(uncommon)

Euthyroid Sick euthyroid

(FT3 = ↓),

Hypopituitarism

(other pituitary

hormones = ↓,

Low Hyperthyroidism

(FT3 = ↑)

T3 thyrotoxicosis

(FT3 = ↑),

Subclinical

hyperthyroidism

(FT3 = N/↓),

Hypopituitarism

(other pituitary

hormones = ↓),

Sick euthyroid

(severe)

(FT3 = ↓),

Free Thyroxine Measurements in Common

Conditions Affecting Thyroid-binding Proteins

Clinical conditions Free T4 Levels

Near Normal Concentration of Serum-Binding Proteins

Hypothyroidism Low

Hyperthyroidism High

Hyperestrogenism Low

Abnormal Concentration of Serum-Binding Proteins

TBG excess Normal

TBG deficiency High

Dysalbuminemia Normal

Hypoalbuminemia Normal

T4 autoantibody Normal

Low total T4 non-thyroidal illness Normal or High

High total T4 non-thyroidal illness Normal or High

Free T4 and Free T3 in Various Disease Conditions

1. Hyperthyroidism

¾ Hyperthyroidism produces a primary increase in

free T4, whereas estrogens and idiopathic or genetic

conditions may produce a primary increase in TBP. In

both cases [T4 and TBP] increase, but in the former,

the patient is ill and requires treatment; in the latter,

the patient is euthyroid. Likewise, a low serum [T4 and

TBP] may be due to a primary decrease in [FT4] or to

a primary decrease in [TBP]. It is, therefore, clinically

important to differentiate between changes in [T4 and

TBP] that are due to primary changes in [FT4] (e.g.

hyper-or hypothyroidism) and those that are due to

primary changes in [TBP].

¾ Serum TSH level is low in all forms of hyperthyroidism

except in rare cases in which hyperthyroidism is

mediated by TSH itself. When TSH level is low, free

T4 concentration should be measured and will be

elevated in most cases of hyperthyroidism. Finding a

low TSH level and an elevated free T4 level is usually

sufficient to establish the diagnosis of hyperthyroidism.

If TSH level is low but free T4 level is normal, a T3

measurement should be performed, since serum T3

concentration is often elevated earlier in the course

of hyperthyroidism and to a greater degree than is T4

concentration. Because only the free fraction of T3 is

active, the estimation of free T3 is helpful in adjusting

the total T3 for variations in binding proteins. It should

be remembered that numerous medications as well as

both acute and chronic illness may cause a transient

lowering of T3 concentration as well as a reduction in

TSH level.

¾ In Graves’ disease or toxic adenomas, serum total T3

and free T3 levels are typically elevated to a greater

degree than total T4 and free T4.

¾ T3 toxicosis—encountered in about 5% of hyperthyroid

population—total T3 and free T3 values increase.

¾ Serum total T4 and free T4 are disproportionately

elevated to a greater degree than total T3 and free T3

values in most patients with toxic multinodular goiter.

¾ Monitoring total T3 and free T3 values may also be of

importance in evaluating both the severity and the

response therapy in patients being treated for thyroid

storm or crisis in that the antithyroid drug therapies are

focused on reducing both thyroid gland T3 secretion

and peripheral tissue T3 production from T4.

2. Nonthyroidal Illness

¾ In nonthyroidal illness (NTI) and altered states of

nutrition there are two categories:

Low T3 state: Decrease in total T3 and free T3 while

maintaining normal total T4 and free T4. Observed in

mild or moderate NTIs or states of caloric deprivation

(< 400 cal)

Low T3-T4 state: Total T4 also decreased, a case of

severe NTI.

¾ Free T4 levels remain within or near the normal range

of values as serum total T4 levels decline.

The Endocrine System 751

¾ Decreased total T3 or normal free T4 or increased free

T4 results from acquired defect in serum T4-binding

proteins which accompany NTI.

¾ Also common are increases in the levels of the free

fraction of T4 and T3 which are caused by decrease

in serum concentrations of thyroid hormone-binding

proteins, changes in binding properties induced by

circulating inhibitors and drugs, or both. Low levels

of total T4 may be seen in nonthyroidal illnesses, but

total T4 concentrations in these patients are usually

normal or above normal as determined using reference

methods.

¾ Thus in nonthyroidal illnesses, abnormal thyroid test

results are not necessarily indicative of thyroid disease

but may demonstrate adaptations to the catabolic

state, many of these changes revert to normal when the

patient recovers.

¾ Several test abnormalities may be seen in nonthyroidal

illnesses in euthyroid patients (the ‘euthyroid sick

syndrome’). The most common abnormalities are a

reduction in the serum total T3 concentration and an

elevation in the serum level of free T3. Also common are

increases in the levels of the free fraction of T4 and T3

which are caused by decrease in serum concentrations

of thyroid hormone-binding proteins, changes in

binding properties induced by circulating inhibitors

and drugs, or both. Low levels of total T4 may be seen

in nonthyroidal illnesses, but total T4 concentrations in

these patients are usually normal or above normal as

determined using reference methods.

3. Hypothyroidism

¾ If total T4 (or free T4) level is normal, hypothyroidism is

most unlikely: however, a low T4 concentration is often

seen in the euthyroid sick.

Assay Choice Application

For definitive diagnosis, assessment of both serum TSH

and free T4 is required, but a more limited approach

can be used for initial case finding and follow-up. In the

interests of cost effectiveness, evaluation of thyroid status

may often begin with an assay for either serum TSH or free

T4, followed by further algorithm-based assessment if the

initial result is abnormal. As an initial test, serum total

T4 measurements give an unacceptable rate of abnormal

results, due to the frequency of abnormalities in serum

thyroid hormone-binding proteins.

Four distinct clinical situations in which evaluation

of thyroid function is done can be considered: testing of

unselected populations for case finding or screening,

testing of untreated patients who have clinical features

that suggest thyroid disease, assessment of the response

to treatment for thyroid dysfunction, and evaluation of

patients in whom associated illness or drug therapy are

likely to complicate clinical and laboratory assessment or

whose initial results are atypical or unclear.

Screening and Case Finding

About 2 to 7% of women over age 40 years may have

slightly elevated serum TSH concentrations. The case for

routine assessment of thyroid status is strongest in elderly

women who have any symptoms that could be consistent

with hypothyroidism. Among hospitalized patients, the

large majority of abnormal results are due to nonthyroidal

illness or medications.

Most persons found to have either high or low

serum TSH values in screening or case-finding studies

have subclinical disease.

Comments

Search This Blog

Archive

Show more

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

علاقة البيبي بالفراولة بالالفا فيتو بروتين

التغيرات الخمس التي تحدث للجسم عند المشي

إحصائيات سنة 2020 | تعداد سكَان دول إفريقيا تنازليا :

ما هو الليمونير للأسنان ؟

ACUPAN 20 MG, Solution injectable

CELEPHI 200 MG, Gélule

الام الظهر

VOXCIB 200 MG, Gélule

ميبستان

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

Popular posts from this blog

TRIPASS XR تري باس

CELEPHI 200 MG, Gélule

ZENOXIA 15 MG, Comprimé

VOXCIB 200 MG, Gélule

Kana Brax Laberax

فومي كايند

بعض الادويه نجد رموز عليها مثل IR ، MR, XR, CR, SR , DS ماذا تعني هذه الرموز

NIFLURIL 700 MG, Suppositoire adulte

Antifongiques مضادات الفطريات

Popular posts from this blog

Kana Brax Laberax

TRIPASS XR تري باس

PARANTAL 100 MG, Suppositoire بارانتال 100 مجم تحاميل

الكبد الدهني Fatty Liver

الم اسفل الظهر (الحاد) الذي يظهر بشكل مفاجئ bal-agrisi

SEDALGIC 37.5 MG / 325 MG, Comprimé pelliculé [P] سيدالجيك 37.5 مجم / 325 مجم ، قرص مغلف [P]

نمـو الدمـاغ والتطـور العقـلي لـدى الطفـل

CELEPHI 200 MG, Gélule

أخطر أنواع المخدرات فى العالم و الشرق الاوسط

Archive

Show more